The Rossy Progressive Supranuclear Palsy Centre: Creation and Initial Experience.
Can J Neurol Sci
; 50(6): 845-852, 2023 Nov.
Article
en En
| MEDLINE
| ID: mdl-36600512
ABSTRACT
OBJECTIVE:
To describe the development and initial experience of a clinical research program in progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) in Canada The Rossy PSP Centre, to share the data acquisition tools adopted, and to report preliminary results.METHODS:
Extensive demographic and longitudinal clinical information is collected every 6 months using standardized forms. Biofluids are collected for biobanking and genetic analysis, and many patients are enrolled in neuroimaging research protocols. Brain donation is an important component of the program, and standardized processing protocols have been established, including very short death to autopsy times in patients undergoing medical assistance in dying.RESULTS:
Between Oct 2019 and Dec 2021, 132 patients were screened, 91 fulfilling criteria for PSP and 19 for CBS; age 71 years; 41% female; duration 5 years, age-of-onset 66 years. The most common symptoms at onset were postural instability and falls (45%), cognitive-behavioral changes (22%), and Parkinsonism (9%). The predominant clinical phenotype was Richardson syndrome (82%). Levodopa and amantadine resulted in partial and short-lasting benefit.CONCLUSIONS:
The Rossy PSP Centre has been established to advance clinical and basic research in PSP and related tauopathies. The extent of the clinical data collected permits deep phenotyping of patients and allows for future clinical and basic research. Preliminary results showed expected distribution of phenotypes, demographics, and response to symptomatic treatments in our cohort. Longitudinal data will provide insight into the early diagnosis and management of PSP. Future steps include enrollment of patients in earlier stages, development of biomarkers, and fast-tracking well-characterized patients into clinical trials.
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Guideline
/
Screening_studies
Idioma:
En
Año:
2023
Tipo del documento:
Article